A Phase II Trial with Cisplatin-Paclitaxel Cytotoxic Treatment and Concurrent External and Endocavitary Radiation Therapy in Locally Advanced or Recurrent Cervical Cancer

Publisher： Karger

E-ISSN： 1423-0232|70|1|19-24

ISSN： 0030-2414

Source： Oncology, Vol.70, Iss.1, 2006-03, pp. : 19-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Trial of Primary Radiation Therapy and Concurrent Chemotherapy for Patients with Locally Advanced Pancreatic Cancer

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 493-499

Karger

Access to resources Recommend Favorite

Concurrent Chemoradiotherapy with a Novel Fluoropyrimidine, S-1, and Cisplatin for Locally Advanced Esophageal Cancer: Long-Term Results of a Phase II Trial

By  

Oncology, Vol. 84, Iss. 6, 2013-05 ,pp. : 342-349

Karger

Access to resources Recommend Favorite

Cisplatin-Docetaxel Induction plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer Patients: A Phase II Trial

By  

Oncology, Vol. 83, Iss. 6, 2012-09 ,pp. : 321-328

Karger

Access to resources Recommend Favorite

Phase II Study of Irinotecan and Cisplatin as First-Line Chemotherapy in Advanced or Recurrent Cervical Cancer

By  

Oncology, Vol. 58, Iss. 1, 2000-01 ,pp. : 31-37

Karger

Access to resources Recommend Favorite

A Phase II Multi-Center Study of Triple Therapy with Paclitaxel, S-1 and Cisplatin in Patients with Advanced Gastric Cancer

By  

Oncology, Vol. 80, Iss. 1-2, 2011-06 ,pp. : 76-83

Karger

Access to resources Recommend Favorite